Skip to main content
Equibles

Beneficial ownership — 13D / 13G

85,680 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Nantahala Capital Management, LLC UNCY Unicycive Therapeutics, Inc. 13G/A 9.99% 3mo
AQR CAPITAL MANAGEMENT LLC PALO Paloma Acquisition Corp I 13G/A 4.63% 3mo
Alyeska Investment Group, L.P. AGIG Abundia Global Impact Group, Inc. 13G/A 4.86% 3mo
Balyasny Asset Management L.P. TALK Talkspace, Inc. 13G/A 4.09% 3mo
AQR CAPITAL MANAGEMENT LLC SPKLF Spark I Acquisition Corp 13G/A 7.02% 3mo
Stier Jennifer ANGI Angi Inc. 13G/A 7% 3mo
BIOTECHNOLOGY VALUE FUND L P NKTR Nektar Therapeutics 13G/A 7.1% 3mo
Durable Capital Partners LP VSEC Vse Corp 13G/A 3.5% 3mo
Fort Baker Capital Management LP DRDB Roman DBDR Acquisition Corp. II 13G/A 0% 3mo
Orbis Investment Management Limited QXO QXO, Inc. 13G/A 10.2% 3mo
PRICE T ROWE ASSOCIATES INC /MD/ HXL Hexcel Corp 13G/A 7.8% 3mo
T. Rowe Price Investment Management, Inc. IMNM Immunome Inc. 13G/A 17.4% 3mo
VAN ECK ASSOCIATES CORP EU enCore Energy Corp. 13G/A 7.8% 3mo
AMERIPRISE FINANCIAL INC BUR Burford Capital Ltd 13G/A 8.4% 3mo
RTW INVESTMENTS, LP CGON CG Oncology, Inc. 13G/A 9.7% 3mo
AMERIPRISE FINANCIAL INC GDDY GoDaddy Inc. 13G 9.2% 3mo
Venrock Healthcare Capital Partners III, L.P. ORKA Oruka Therapeutics, Inc. 13G/A 7.4% 3mo
Bastion Trading Limited SKYA SkyAI, Inc. 13G/A 9.9% 3mo
COOPER CREEK PARTNERS MANAGEMENT LLC WW Ww International, Inc. 13G/A 9.6% 3mo
GOLDMAN SACHS GROUP INC BREZ Breeze Acquisition Corp. II 13G 6.7% 3mo
Venrock Healthcare Capital Partners III, L.P. ARTV Artiva Biotherapeutics, Inc. 13G/A 4.2% 3mo
DME Capital Management, LP DCH Dauch Corp 13G 5.2% 3mo
Solas Capital Management, LLC MODD Modular Medical, Inc. 13G/A 9.9% 3mo
COHEN & STEERS, INC. AKR Acadia Realty Trust 13G/A 14.13% 3mo
FARALLON CAPITAL MANAGEMENT LLC TYRA Tyra Biosciences, Inc. 13G/A 0% 3mo
ALLIANCEBERNSTEIN L.P. AMWD American Woodmark Corp 13G/A 0% 3mo
Driehaus Capital Management LLC DFTX Definium Therapeutics, Inc. 13G/A 5.36% 3mo
ARISTEIA CAPITAL, L.L.C. MYX Maywood Acquisition Corp. 2 13G 5.24% 3mo
Pentwater Capital Management LP CNTA Centessa Pharmaceuticals plc 13G/A 0% 3mo
Fourthstone LLC ATLO Ames National Corp 13G/A 0.19% 3mo
North Reef Capital Management LP EGBN Eagle Bancorp Inc 13G/A 5.62% 3mo
TOMS Capital Investment Management LP GLNG Golar Lng Ltd 13G/A 0.1% 3mo
BAKER BROS. ADVISORS LP IMTX Immatics N.V. 13G/A 7% 3mo
COHEN & STEERS, INC. KRC Kilroy Realty Corp 13G/A 4.96% 3mo
Alyeska Investment Group, L.P. BATL Battalion Oil Corp 13G/A 0% 3mo
G1 Execution Services, LLC FINV FinVolution Group 13G/A 13.5% 3mo
ARMISTICE CAPITAL, LLC IVF INVO Fertility, Inc. 13G/A 4.99% 3mo
Newtyn Management, LLC PAR Par Technology Corp 13G/A 5.5% 3mo
HIGHBRIDGE CAPITAL MANAGEMENT LLC ALPX Alpex Acquisition Corp 13G 8% 3mo
Divisadero Street Capital Management, LP CTRN Citi Trends Inc 13G/A 8.5% 3mo
AQR CAPITAL MANAGEMENT LLC ALF Centurion Acquisition Corp. 13G/A 8.24% 3mo
LONDON CO OF VIRGINIA UNF Unifirst Corp 13G/A 5.09% 3mo
FULLER & THALER ASSET MANAGEMENT, INC. GPK Graphic Packaging Holding Co 13G/A 7.06% 3mo
Aeroequity GP, LLC YSS York Space Systems Inc. 13G/A 23.96% 3mo
ARMISTICE CAPITAL, LLC RPID Rapid Micro Biosystems, Inc. 13G 7.29% 3mo
ALLIANCEBERNSTEIN L.P. PTLO Portillo's Inc. 13G/A 0.1% 3mo
Charles A. Davis BETA BETA Technologies, Inc. 13G/A 7.3% 3mo
VK Services, LLC FTH Faeth Therapeutics, Inc. 13G 10.2% 3mo
Samsara BioCapital, L.P. ELOX Eloxx Pharmaceuticals, Inc. 13G 9.9% 3mo
Snow Rothschild Acquisition Sponsor LLC ISNR Snow Rothschild Acquisition Corp. 13G 20% 3mo